I asked our team of Delish editors to weigh in with their favorite kitchen products to buy at Walmart—and they delivered.

Two years after buying CinCor Pharma for $1.3 billion, AstraZeneca has reported that the main asset in the deal, for uncontrolled or treatment-resistant hypertension, has cleared a phase 3 trial.